Abstract
79 The routine use of Granulocyte-colony stimulating factor (G-CSF) with chemo-immunotherapy does not affect clinical outcomes in lung adenocarcinoma
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have